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In Scotland, since 1975–1979 (world) age-standardised incidence of squamous cell carcinoma of the anus has more than doubled,
reaching 0.37 per 100000 in males and 0.55 in females during 1998–2002, being somewhat higher in socioeconomically deprived
areas.
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Cancers of the anus and anal canal are relatively rare, accounting
for approximately 2% of all cancers of the large bowel (Parkin et al,
2002). However, in recent decades the incidence of anal cancer has
been reported to be increasing in a number of countries, including
the United States (Johnson et al, 2004; Chiao et al, 2005), Denmark
(Frisch et al, 1993), and Sweden (Goldman et al, 1989). In the
United States, particular increases have been observed in never
married men, and in men living in the San Francisco Bay area,
even before the HIV/AIDS era (Melbye et al, 1994a; Biggar and
Melbye, 1996; Cress and Holly, 2003).
In the present study, we describe secular trends in incidence of
squamous cell carcinoma of the anus in Scotland before and
during the HIV epidemic, and describe geographical and socio-
economic variations in incidence within Scotland.
MATERIALS AND METHODS
Incident cases of ‘malignant neoplasms of the anus and anal canal’
(ICD-9 154.2, 154.3, and 154.8; ICD-10 C21) for the years 1975–
2002 were extracted from the Scottish Cancer Registry. This
registry covers the whole of Scotland (population approximately
5.1 million); data quality is believed to be high, both in terms of
accuracy and completeness (Harris et al, 1998; Brewster et al,
2002). A range of patient and tumour-related information is
collected, including demographic and diagnostic details. For the
present analysis, tumours were categorised according to the
histological classification developed by the International Agency
for Research on Cancer (Parkin et al, 2002), in which squamous
cell carcinomas are defined by ICD-O morphology codes in the
range M-8050/3–M-8076/3.
Mid-year population estimates, derived from the Annual
Reports of the Registrar General for Scotland (Registrar General
for Scotland, 1976–2003), were used to calculate sex-specific, 5-
year moving average age-adjusted incidence rates by direct
standardisation to the World Population (Waterhouse et al.,
1976). Age- and sex-specific incidence rates were calculated for
three diagnosis periods: a pre-HIV period (1975–1981); the HIV
period (1982–1995); and the highly active antiretroviral therapy
(HAART) period (1996–2002) (Chiao et al, 2005).
The incidence of squamous cell carcinoma of the anus by sex in
each health board area of residence was compared to the incidence
in Scotland as a whole for the period 1975–2002 by indirect
standardisation to produce standardised incidence ratios (SIR);
exact 95% confidence intervals were calculated (Breslow and Day,
1987). To investigate the influence of socioeconomic status on risk
during 1975–2002, sex-specific age-standardised incidence rates
were calculated by Carstairs deprivation quintiles (Morris and
Carstairs, 1991), based on the 1981 census for the period 1975–
1985 and the 1991 census thereafter. The statistical significance of
trends in incidence by deprivation quintile was tested by Poisson
regression.
RESULTS
For the total period, 1975–2002, the percentage distribution of
histological categories of anal cancer in Scotland was as follows:
squamous cell carcinoma (56.3%); basaloid and cloacogenic
carcinoma (12.0%); adenocarcinoma (21.2%); other specified
carcinomas (1.9%); unspecified carcinomas (4.8%); melanoma
(2.3%); other specified cancers (0.0%); and unspecified cancers
(1.6%). Compared to females, males had a lower percentage of
squamous cell carcinomas (52.1 vs 59.1%), and of basaloid and
cloacogenic carcinomas (9.9 vs 13.3%), but a higher percentage of
adenocarcinomas (27.2 vs 17.3%). Hereafter, the results relate to
squamous cell carcinomas only.
In total, 757 cases of squamous cell carcinoma (278 males, 479
females) were registered with an incidence date falling within the
28-year period of study (1975–2002). Secular trends in age-
standardised incidence rates by sex are shown in Figure 1. In
males, the rates per 100000 increased from 0.14 to 0.17 in the late
1970s to around 0.37 in the late 1990s, but with a peak of 0.44 in
the period 1993–1997. In females, the incidence rate has generally
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of 0.55 in the period 1998–2002.
Figure 2A and B showing for each sex age-specific rates for three
consecutive periods of diagnosis (1975–1981, 1982–1995, and
1996–2002), demonstrate an increase in incidence over time
across most of the age groups, particularly in middle age.
Comparing incidence in each health board area to Scotland as a
whole during the whole period 1975–2002, there were no
statistically significantly increased risks, with the exception of
males in Lothian Health Board area (which includes the city of
Edinburgh), for whom the SIR was 165.3 (95% confidence intervals
129.9–210.4).
Figure 3 shows the age-standardised incidence rates of
squamous cell carcinoma of the anus by Carstairs deprivation
quintile and sex, for patients diagnosed during the period 1975–
2002. Rates were somewhat higher in deprived areas, but this trend
is only significant for females (P-values for trend: 0.173 and 0.027,
for males and females, respectively).
DISCUSSION
Although rare in absolute terms, over nearly three decades, the risk
of squamous cell carcinoma of the anus in Scotland has more than
doubled in both sexes. Available data published routinely by the
Office for National Statistics in London indicate that, age
standardised to the European standard population, incidence rates
per 100000 of anal cancer (ICD-10 C21, all histologies combined)
in England have increased between 1986 and 2003 from 0.7 to 1.1
in males, and from 0.6 to 1.3 in females (Office for National
Statistics, 2001, 2005).
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Figure 1 Age-standardised incidence rates of squamous cell carcinoma
of the anus by year of diagnosis (5-year moving averages) and sex, Scotland,
1975–2002.
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Figure 2 (A) Age-specific incidence rates of squamous cell carcinoma of
the anus in males, by period of diagnosis, Scotland, 1975–2002. (B): Age-
specific incidence rates of squamous cell carcinoma of the anus in females,
by period of diagnosis, Scotland, 1975–2002.
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Figure 3 Age-standardised incidence rates of squamous cell carcinoma
of the anus by deprivation quintile and sex, Scotland, 1975–2002.
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case–control studies, are a history of multiple sexual partners,
men having sex with men, receptive anal intercourse (especially in
men), a history of other anogenital cancers in women, a history of
sexually transmitted infections, and current smoking (Frisch et al,
1997, 1999; Tseng et al, 2003; Daling et al, 2004), though a study in
Denmark and Sweden found the risk from smoking only in
premenopausal women (Frisch et al, 1999). The risk of anogenital
cancers is also recognised to be increased among renal transplant
recipients (Penn, 1986; Sillman et al, 1997). Although high risks of
anal cancer have been found in homosexual men with AIDS, the
contribution of HIV infection is unclear because homosexual men
were at increased risk even before the AIDS epidemic (Melbye
et al, 1994b). Irrespective of HIV status, a high proportion of anal
cancers have detectable human papillomavirus (HPV), notably
HPV type 16, suggesting that infection with HPV is a necessary
cause of anal cancer (Frisch et al, 1997; Daling et al, 2004). An
association between HPV seropositivity and risk of subsequent
anal and perianal skin cancer has also been demonstrated in a
prospective study (Bjorge et al, 2002).
Unpublished data from the National Survey of Sexual Attitudes
and Lifestyles (Natsal) 2000 suggests that, in Scotland, the reported
prevalence of receptive anal intercourse within the previous year
among 16–44-year olds was substantially higher in women
(11.16%, 95% confidence intervals 7.71–15.87%) than in men
(0.71%, 0.25–1.97%) (Dr Catherine Mercer, personal communica-
tion). Although a lower prevalence was reported in the same age
group in the equivalent survey in 1990, this was again much higher
in women. It seems reasonable to assume that this sex difference
has existed for some years, and may explain, at least in part, the
higher incidence of squamous cell carcinoma of the anus among
women in our study.
While the risk of cancer in the pre-HAART era has been shown
to be high among a cohort of HIV-positive persons in Scotland
compared to national rates, no case of anal cancer has been
reported in the HIV-positive cohort up to the end of 1996
(Allardice et al, 2003). Follow-up of this cohort is currently being
extended to the end of 2003, and based on experience in other
countries, it seems not unlikely that cases of anal cancer will be
recorded.
Although our data suggest that the age-standardised squamous
cell anal cancer incidence in Scotland began to plateau or even
decrease in males in the HAART period, rates have continued to
increase overall in females, and in middle age groups of both sexes.
In the US, during the same period, incidence has continued to
increase in all age groups over 35 years in males, and in middle age
groups in females (Chiao et al, 2005). The risk of anal cancer has
also been found to be higher in the HAART compared to the pre-
HAART period among an HIV-seropositive cohort in London
(Bower et al, 2004), and among a cohort of patients with AIDS in
San Diego (Diamond et al, 2005). This is consistent with the
observation that among HIV-infected men who have sex with men,
the prevalence of anal squamous intraepithelial lesions (SIL),
including high-grade SIL, and anal HPV infection remains
high, despite immune restoration under HAART (Piketty et al,
2004). As there is some evidence that duration of HIV infection is
more important than immune status in invasive anal carcinoma
risk (Frisch et al, 2000; Fagan et al, 2005), this cancer may become
an increasing problem among the HIV-positive population
as HAART improves long-term survival (Frisch, 2002; Diamond
et al, 2005; Fagan et al, 2005). This may be compounded by the
apparent increase in high-risk sexual behaviour among homo-
sexual men in Scotland between 1996 and 2002 (Hart and
Williamson, 2005).
Given the risk factor profile of squamous cell carcinoma of the
anus, the excess risk of this disease in males resident in Lothian
Health Board during the period 1975–2002 is consistent with the
higher rates of rectal gonococcal infection in Lothians than
Scotland as a whole (suggesting higher rates of unprotected anal
intercourse) (Young et al, 1997).
A Los Angeles study suggested that the risk of anal carcinoma
increased with decreasing social class (Peters et al, 1984). In our
study, the absence of a significant relationship with social
deprivation in males may simply be due to our relatively small
numbers of cases. Additionally, it may reflect misclassification of
socioeconomic status since the Carstairs deprivation index is
based on place of residence at diagnosis, the characteristics being
measured at a single point in time (here, at the 1981 and 1991
censuses).
Since currently available data do not support the screening of
high-risk groups for anal cancer or its probable precursor, anal
intraepithelial neoplasia (Anderson et al, 2004), health education
should aim at reducing high-risk behaviour and encouraging early
presentation with symptomatic disease. In the longer term, newly
emerging HPV vaccines may enable risk reductions (Geipert,
2005).
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